Phiri J, Morreel S, De Graeve D, Beutels P, Pairon A, Philips H, Monsieurs K, Verhoeven V, Willem L. (2026). Economic evaluation of diverting low-risk patients from the emergency department to adjacent out-of-hours primary care in Belgium. Primary health care research & development, (27)
Affaticati F, Ha MK, Gehrmann T, De Boeck I, Kuznetsova M, Vandoren R, Van Deuren V, Alcedo S, Jansens H, De Reu H, Schippers J, Peeters K, Bartholomeus E, Van Ierssel S, Coenen S, Naesens R, Ariën KK, Vercauteren K, Vlieghe E, Beutels P, Van Damme P, Goossens H, Lion E, Suls A, Soentjens P, Lebeer S, Laukens K, Meysman P, Ogunjimi B. (2026). Blood transcriptome bridges orthogonal immunotypes and gut microbiome enterotypes in humans. Cell reports, 45(8)
Trautmannsberger I, Bösl S, Adamek I, Apfelbacher C, Beutels P, Essers B, Ravens-Sieberer U, Weil-Olivier C, Nenna R, Wetzke M, Mader S, Tischer C, Zimmermann LJI, . (2026). Higher severity of infant RSV infections is associated with lower parental quality of life - a European observational study. Journal of patient-reported outcomes, 10(1)
Mao Z, Bilcke J, Pepermans K, Beutels P. (2026). Estimating EQ-5D-5L quality-adjusted life year weights from GHQ-12 mental health data: a large sample exploration of four mapping methods. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Furquim d'Almeida A, Ho E, Beutels P, Maertens K, Hens N, Van Damme P, Theeten H, Vanwolleghem T. (2026). Prevalence of hepatitis B surface antibodies and hepatitis B exposure in Belgium: results from a nationwide population-based serosurvey. BMC infectious diseases
Li X, Willem L, Roberfroid D, Bilcke J, Castanares Zapatero D, De Meester C, Mao Z, Thiry N, Beutels P. (2026). Cost-effectiveness of maternal vaccine and/or monoclonal antibody strategies against respiratory syncytial virus in Belgian infants. NPJ vaccines
Wambua J, Lang JC, Ogunjimi B, Hens N, Beutels P. (2026). Comparative analysis of the impact of chickenpox and herpes zoster vaccination in Belgium under two different exogenous boosting mechanisms. PloS one, 21(3)
Carmona A, Breugelmans JG, Beutels P, Sánchez BM, Miller E, Moyersoen J, Nair H, Nguyen JL, Sánchez AO, Rebry G, Smith PG, Sullivan SG, Torcel-Pagnon L, Van Aalst R, Praet N, Gomez JP, Rousculp M, Savic M, Wang C, Bollaerts K. (2026). id.DRIVE: a public-private partnership for infectious disease surveillance, vaccine research, and pandemic preparedness in Europe and beyond. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Furquim d'Almeida A, Ho E, Schüttler C, Beutels P, Hens N, Dudareva S, Van Damme P, Theeten H, Vanwolleghem T. (2026). Combined HBsAg and anti-HBc testing is required to estimate hepatitis B virus seroprevalence in a low-endemic country: findings from a nationwide population-based serosurvey, Belgium, 2020. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 31(6)
Li X, Willem L, Johannesen CK, Urchueguía-Fornes A, Lehtonen T, Osei-Yeboah R, Salo H, Orrico-Sánchez A, Díez-Domingo J, Jit M, , Bilcke J, Nair H, Beutels P. (2025). Influential drivers of the cost-effectiveness of respiratory syncytial virus vaccination in European older adults: a multi-country analysis. BMC medicine, 23(1)
Li X, Bilcke J, Asare EO, Wenger C, Kwon J, Bont L, Beutels P, Pitzer VE. (2025). How well do disease-specific studies and WHO-CHOICE cost estimates align? Example of estimating cost per episode of diarrhoea and respiratory syncytial virus in 128 low-income and middle-income countries. BMJ global health, 10(8)
Kissling E, Nunes B, Hooiveld M, Martínez-Baz I, Monge S, Robertson C, Knol M, Sève N, Mlinarić I, Domegan L, Machado A, Whitaker H, Lazar M, Meijer A, Enkirch T, Casado I, Pérez-Gimeno G, William N, Enouf V, Filipović SK, McKenna A, Rodrigues AP, de Lusignan S, Timnea OC, Latorre-Margalef N, Castilla J, Pozo F, Hamilton M, Masse S, Ilić M, Basile L, O'Donnell J, Guiomar R, Riess M, Popescu RM, Rose AMC, Andrews N, Bacci S, Celentano LP, Valenciano M, Moren A, Beutels P, Hens N, Ecdc Primary Care Study Teams OBOI. (2025). Recommendations for estimating and reporting vaccine effectiveness by time since vaccination: a COVID-19 case study. American journal of epidemiology
Ha MK, Postovskaya A, Kuznetsova M, Meysman P, Van Deuren V, Van Ierssel S, De Reu H, Schippers J, Peeters K, Besbassi H, Heyndrickx L, Willems B, Mariën J, Bartholomeus E, Vercauteren K, Beutels P, Van Damme P, Lion E, Vlieghe E, Laukens K, Coenen S, Naesens R, Ariën KK, Ogunjimi B. (2025). Celluloepidemiology-A paradigm for quantifying infectious disease dynamics on a population level. Science advances, 11(20)
Mao Z, Zsabokorszky Z, Bilcke J, Beutels P. (2025). Identifying indicators of "success" in managing the COVID-19 pandemic in Europe: insights from an interdisciplinary expert consultation. Archives of public health = Archives belges de sante publique, 83(1)
Dierckx L, Rodriguez-Ruiz JP, Ekinci E, Van Heirstraeten L, Willen L, Cuypers L, Beutels P, Maertens K, Desmet S, Theeten H, Malhotra-Kumar S. (2025). Pneumococcal genotype 23B1 as a driver of increased 23B serotype carriage, penicillin non-susceptibility, and invasive disease in Belgium: a retrospective analysis. Journal of clinical microbiology
Manansala R, Bilcke J, Willem L, Hens N, Beutels P. (2025). Optimizing influenza vaccine allocation by age using cost-effectiveness analysis: A comparison of 6720 vaccination program scenarios in children and adults in Belgium. Epidemics, (51)
Angeli L, Caetano CP, Franco N, Coletti P, Faes C, Molenberghs G, Beutels P, Abrams S, Willem L, Hens N. (2025). Assessing the role of children in the COVID-19 pandemic in Belgium using perturbation analysis. Nature communications, 16(1)
Tsuzuki S, Nguyen HT, Toizumi M, Vo HM, Le HH, Dang DA, Beutels P, Yoshida LM. (2025). Antimicrobial use for influenza-like illnesses in Nha Trang, Vietnam: a cross-sectional study. BMJ open, 15(8)
Chhajlani S, Kuiper J, Beutels P, Borbath I, Dercksen W, Deroose CM, Heemskerk S, Polinder S, Roelant E, Smits E, Verhaegen I, Van der Massen I, Walenkamp A, de Herder WW, Peeters M, Hofland J, Vandamme T, . (2025). Somatostatin analogue continuation upon progression in patients with gastroenteropancreatic neuroendocrine tumour (SAUNA trial): a randomised controlled trial protocol. BMJ open, 15(7)
Ekinci E, Van den Bosch E, Van Heirstraeten L, Desmet S, Lammens C, Goossens H, Van Damme P, Verhaegen J, Beutels P, Malhotra-Kumar S, Maertens K, Theeten H. (2025). Back to the future? Drastic drop in serotype 19A carriage in daycare centers within two years after a second switch to PCV13 in Belgium. Human vaccines & immunotherapeutics, 21(1)
Varbanova V, Hens N, Beutels P. (2024). Determinants of COVID-19 vaccination coverage in European and Organisation for Economic Co-operation and Development (OECD) countries. Frontiers in public health, (12)
Besbassi H, Elias G, Meysman P, Jansens H, Laukens K, Damme PV, Hens N, Beutels P, Ogunjimi B. (2024). Modeling antigen-specific T cell dynamics following Hepatitis B Vaccination indicates differences between conventional and regulatory T cell dynamics. Vaccine, 42(21)
Jarvis CI, Coletti P, Backer JA, Munday JD, Faes C, Beutels P, Althaus CL, Low N, Wallinga J, Hens N, Edmunds WJ. (2024). Social contact patterns following the COVID-19 pandemic: a snapshot of post-pandemic behaviour from the CoMix study. Epidemics, (48)
Mao Z, Crèvecoeur J, Pepermans K, Kind P, Neyens T, Beutels P. (2024). A comparison of items and constructs of standardised health-related quality of life and mental well-being measures. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Sherratt K, Srivastava A, Ainslie K, Singh DE, Cublier A, Marinescu MC, Carretero J, Garcia AC, Franco N, Willem L, Abrams S, Faes C, Beutels P, Hens N, Müller S, Charlton B, Ewert R, Paltra S, Rakow C, Rehmann J, Conrad T, Schütte C, Nagel K, Abbott S, Grah R, Niehus R, Prasse B, Sandmann F, Funk S. (2024). Characterising information gains and losses when collecting multiple epidemic model outputs. Epidemics, (47)
Willem L, Abrams S, Franco N, Coletti P, Libin PJK, Wambua J, Couvreur S, André E, Wenseleers T, Mao Z, Torneri A, Faes C, Beutels P, Hens N. (2024). The impact of quality-adjusted life years on evaluating COVID-19 mitigation strategies: lessons from age-specific vaccination roll-out and variants of concern in Belgium (2020-2022). BMC public health, 24(1)
Mao Z, Pepermans K, Beutels P. (2024). Relating mental health, health-related quality of life and well-being in the aftermath of the COVID-19 pandemic: A cross-sectional comparison in 14 European countries in early 2023. Public health, (238)
Tran PB, Nikolaidis GF, Abatih E, Bos P, Berete F, Gorasso V, Van der Heyden J, Kazibwe J, Tomeny EM, Van Hal G, Beutels P, van Olmen J. (2024). Multimorbidity healthcare expenditure in Belgium: a 4-year analysis (COMORB study). Health research policy and systems, 22(1)
Phiri J, Morreel S, De Graeve D, Philips H, Beutels P, Verhoeven V, Willem L. (2024). The need for a broad perspective when assessing value-for-money for out-of-hours primary care. Primary health care research & development, (25)
Li X, Bilcke J, Asare EO, Wenger C, Kwon J, Bont L, Beutels P, Pitzer VE. (2024). Cost per episode of diarrhea and respiratory syncytial virus (RSV) in 128 low- and middle-income countries: how well do disease-specific and WHO-CHOICE estimates align?. medRxiv : the preprint server for health sciences
Mao Z, Li X, Jit M, Beutels P. (2024). COVID-19-related health utility values and changes in COVID-19 patients and the general population: a scoping review. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Reichmuth ML, Heron L, Beutels P, Hens N, Low N, Althaus CL. (2024). Social contacts in Switzerland during the COVID-19 pandemic: Insights from the CoMix study. Epidemics, (47)
Boeren M, de Vrij N, Ha MK, Valkiers S, Souquette A, Gielis S, Kuznetsova M, Schippers J, Bartholomeus E, Van den Bergh J, Michels N, Aerts O, Leysen J, Bervoets A, Lambert J, Leuridan E, Wens J, Peeters K, Emonds MP, Elias G, Vandamme N, Jansens H, Adriaensen W, Suls A, Vanhee S, Hens N, Smits E, Van Damme P, Thomas PG, Beutels P, Ponsaerts P, Van Tendeloo V, Delputte P, Laukens K, Meysman P, Ogunjimi B. (2024). Lack of functional TCR-epitope interaction is associated with herpes zoster through reduced downstream T cell activation. Cell reports, 43(4)
Rozo Posada A, Faes C, Beutels P, Pepermans K, Hens N, Van Damme P, Neyens T. (2024). The effect of spatio-temporal sample imbalance in epidemiologic surveillance using opportunistic samples: An ecological study using real and simulated self-reported COVID-19 symptom data. Spatial and spatio-temporal epidemiology, (50)
Li X, Bilcke J, Beutels P. (2024). Pricey or priceless: cost-effectiveness of respiratory syncytial virus (RSV) prevention in infants. Lancet regional health. Americas, (29)
Antillón M, Li X, Willem L, Bilcke J, , Jit M, Beutels P. (2023). The age profile of respiratory syncytial virus burden in preschool children of low- and middle-income countries: A semi-parametric, meta-regression approach. PLoS medicine, 20(7)
Koltai M, Moyes J, Nyawanda B, Nyiro J, Munywoki PK, Tempia S, Li X, Antillon M, Bilcke J, Flasche S, Beutels P, Nokes DJ, Cohen C, Jit M. (2023). Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa. BMC medicine, 21(1)
Backer JA, Bogaardt L, Beutels P, Coletti P, Edmunds WJ, Gimma A, van Hagen CCE, Hens N, Jarvis CI, Vos ERA, Wambua J, Wong D, van Zandvoort K, Wallinga J. (2023). Dynamics of non-household contacts during the COVID-19 pandemic in 2020 and 2021 in the Netherlands. Scientific reports, 13(1)
Wong KLM, Gimma A, Coletti P, , Faes C, Beutels P, Hens N, Jaeger VK, Karch A, Johnson H, Edmunds W, Jarvis CI. (2023). Social contact patterns during the COVID-19 pandemic in 21 European countries - evidence from a two-year study. BMC infectious diseases, 23(1)
Ekinci E, Willen L, Rodriguez Ruiz JP, Maertens K, Van Heirstraeten L, Serrano G, Wautier M, Deplano A, Goossens H, Van Damme P, Beutels P, Malhotra-Kumar S, Martiny D, Theeten H. (2023). Haemophilus influenzae carriage and antibiotic resistance profile in Belgian infants over a three-year period (2016-2018). Frontiers in microbiology, (14)
Mao Z, Li X, Dacosta-Urbieta A, Billard MN, Wildenbeest J, Korsten K, Martinón-Torres F, Heikkinen T, Cunningham S, Snape MD, Robinson H, Pollard AJ, Postma M, Dervaux B, Hens N, Bont L, Bilcke J, Beutels P, . (2023). Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: A multi-country prospective cohort study in Europe. Vaccine, 41(16)
Tizzani M, De Gaetano A, Jarvis CI, Gimma A, Wong K, Edmunds WJ, Beutels P, Hens N, Coletti P, Paolotti D. (2023). Impact of tiered measures on social contact and mixing patterns of in Italy during the second wave of COVID-19. BMC public health, 23(1)
Natalia YA, Delporte M, De Witte D, Beutels P, Dewatripont M, Molenberghs G. (2023). Assessing the impact of COVID-19 passes and mandates on disease transmission, vaccination intention, and uptake: a scoping review. BMC public health, 23(1)
Besbassi H, Garcia-Fogeda I, Quinlivan M, Breuer J, Abrams S, Hens N, Ogunjimi B, Beutels P. (2023). Modeling antibody dynamics following herpes zoster indicates that higher varicella-zoster virus viremia generates more VZV-specific antibodies. Frontiers in immunology, (14)
Wambua J, Loedy N, Jarvis CI, Wong KLM, Faes C, Grah R, Prasse B, Sandmann F, Niehus R, Johnson H, Edmunds WJ, Beutels P, Hens N, Coletti P. (2023). The influence of COVID-19 risk perception and vaccination status on the number of social contacts across Europe: insights from the CoMix study. BMC public health, 23(1)
Affaticati F, Bartholomeus E, Mullan K, Damme PV, Beutels P, Ogunjimi B, Laukens K, Meysman P. (2023). Multi-View Learning to Unravel the Different Levels Underlying Hepatitis B Vaccine Response. Vaccines, 11(7)
Tsuzuki S, Beutels P. (2023). The estimated disease burden of COVID-19 in Japan from 2020 to 2021. Journal of infection and public health, 16(8)
Møgelmose S, Neels K, Beutels P, Hens N. (2023). Exploring the impact of population ageing on the spread of emerging respiratory infections and the associated burden of mortality. BMC infectious diseases, 23(1)
Varbanova V, Hens N, Beutels P. (2023). Determinants of life-expectancy and disability-adjusted life years (DALYs) in European and Organisation for Economic Co-operation and Development (OECD) countries: A longitudinal analysis (1990-2019). SSM - population health, (24)
Loedy N, Coletti P, Wambua J, Hermans L, Willem L, Jarvis CI, Wong KLM, Edmunds WJ, Robert A, Leclerc QJ, Gimma A, Molenberghs G, Beutels P, Faes C, Hens N. (2023). Longitudinal social contact data analysis: insights from 2 years of data collection in Belgium during the COVID-19 pandemic. BMC public health, 23(1)
Newall AT, Beutels P, Kis Z, Towse A, Jit M. (2023). Placing a value on increased flexible vaccine manufacturing capacity for future pandemics. Vaccine, 41(14)
Devleesschauwer B, Willem L, Jurčević J, Smith P, Scohy A, Wyper GMA, Pires SM, Van Goethem N, Beutels P, Franco N, Abrams S, Van Cauteren D, Speybroeck N, Hens N, De Pauw R. (2023). The direct disease burden of COVID-19 in Belgium in 2020 and 2021. BMC public health, 23(1)
Vujkovic A, Ha M, de Block T, van Petersen L, Brosius I, Theunissen C, van Ierssel SH, Bartholomeus E, Adriaensen W, Vanham G, Elias G, Van Damme P, Van Tendeloo V, Beutels P, van Frankenhuijsen M, Vlieghe E, Ogunjimi B, Laukens K, Meysman P, Vercauteren K. (2023). Diagnosing viral infections through T cell receptor sequencing of activated CD8+ T cells. The Journal of infectious diseases
Getaneh AM, Li X, Mao Z, Johannesen CK, Barbieri E, van Summeren J, Wang X, Tong S, Baraldi E, Phijffer E, Rizzo C, van Wijhe M, Heikkinen T, Bont L, Willem L, Jit M, Beutels P, Bilcke J, . (2023). Cost-effectiveness of monoclonal antibody and maternal immunization against respiratory syncytial virus (RSV) in infants: Evaluation for six European countries. Vaccine, 41(9)
Jit M, Ainslie K, Althaus C, Caetano C, Colizza V, Paolotti D, Beutels P, Willem L, Edmunds J, Nunes B, Namorado S, Faes C, Low N, Wallinga J, Hens N. (2023). Reflections On Epidemiological Modeling To Inform Policy During The COVID-19 Pandemic In Western Europe, 2020-23. Health affairs (Project Hope), 42(12)
Møgelmose S, Vijnck L, Neven F, Neels K, Beutels P, Hens N. (2023). Population age and household structures shape transmission dynamics of emerging infectious diseases: a longitudinal microsimulation approach. Journal of the Royal Society, Interface, 20(209)
Bruyndonckx R, Bilcke J, van der Velden AW, Li X, Hens N, Coenen S, Butler CC, Beutels P. (2022). Impact of Adding Oseltamivir to Usual Care on Quality-Adjusted Life-Years During Influenza-Like Illness. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 25(2)
Van Heirstraeten L, Ekinci E, Smet M, Berkell M, Willen L, Coppens J, Spiessens A, Xavier BB, Lammens C, Verhaegen J, Van Damme P, Goossens H, Beutels P, Matheeussen V, Desmet S, Theeten H, Malhotra-Kumar S. (2022). Detection of SARS-CoV-2 in young children attending day-care centres in Belgium, May 2020 to February 2022. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 27(21)
Franco N, Coletti P, Willem L, Angeli L, Lajot A, Abrams S, Beutels P, Faes C, Hens N. (2022). Inferring age-specific differences in susceptibility to and infectiousness upon SARS-CoV-2 infection based on Belgian social contact data. PLoS computational biology, 18(3)
Pieters Z, Ogunjimi B, Beutels P, Bilcke J. (2022). Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine. PharmacoEconomics
Herzog SA, De Bie J, Abrams S, Wouters I, Ekinci E, Patteet L, Coppens A, De Spiegeleer S, Beutels P, Van Damme P, Hens N, Theeten H. (2022). Seroprevalence of IgG antibodies against SARS-CoV-2 - a serial prospective cross-sectional nationwide study of residual samples, Belgium, March to October 2020. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 27(9)
Varbanova V, Verelst F, Hens N, Beutels P. (2022). Determinants of basic childhood vaccination coverage in European and OECD countries. Human vaccines & immunotherapeutics
Luyten J, Beutels P, Vandermeulen C, Kessels R. (2022). Social preferences for adopting new vaccines in the national immunization program: A discrete choice experiment. Social science & medicine (1982), (303)
Geebelen L, Devleesschauwer B, Lernout T, Tersago K, Parmentier Y, Van Oyen H, Speybroeck N, Beutels P. (2022). Lyme borreliosis in Belgium: a cost-of-illness analysis. BMC public health, 22(1)
Bilcke J, Beutels P. (2022). Authors' Reply to Comment on "Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison Between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine". PharmacoEconomics, 40(10)
Elias G, Meysman P, Bartholomeus E, De Neuter N, Keersmaekers N, Suls A, Jansens H, Souquette A, De Reu H, Emonds MP, Smits E, Lion E, Thomas PG, Mortier G, Van Damme P, Beutels P, Laukens K, Van Tendeloo V, Ogunjimi B. (2022). Preexisting memory CD4 T cells in naïve individuals confer robust immunity upon hepatitis B vaccination. eLife, (11)
Wambua J, Hermans L, Coletti P, Verelst F, Willem L, Jarvis CI, Gimma A, Wong KLM, Lajot A, Demarest S, Edmunds WJ, Faes C, Beutels P, Hens N. (2022). The influence of risk perceptions on close contact frequency during the SARS-CoV-2 pandemic. Scientific reports, 12(1)
Li X, Hodgson D, Flaig J, Kieffer A, Herring WL, Beyhaghi H, Willem L, Jit M, Bilcke J, Beutels P, . (2022). Cost-effectiveness of respiratory syncytial virus preventive interventions in children: a model comparison study. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Drolet M, Godbout A, Mondor M, Béraud G, Drolet-Roy L, Lemieux-Mellouki P, Bureau A, Demers É, Boily MC, Sauvageau C, De Serres G, Hens N, Beutels P, Dervaux B, Brisson M. (2022). Time trends in social contacts before and during the COVID-19 pandemic: the CONNECT study. BMC public health, 22(1)
Stuurman AL, Levi M, Beutels P, Bricout H, Descamps A, Dos Santos G, McGovern I, Mira-Iglesias A, Nauta J, Torcel-Pagnon L, Biccler J, . (2022). Investigating confounding in network-based test-negative design influenza vaccine effectiveness studies-Experience from the DRIVE project. Influenza and other respiratory viruses
Li X, Bilcke J, van der Velden AW, Bruyndonckx R, Coenen S, Bongard E, de Paor M, Chlabicz S, Godycki-Cwirko M, Francis N, Aabenhus R, Bucher HC, Colliers A, De Sutter A, Garcia-Sangenis A, Glinz D, Harbin NJ, Kosiek K, Lindbæk M, Lionis C, Llor C, Mikó-Pauer R, Radzeviciene Jurgute R, Seifert B, Sundvall PD, Touboul Lundgren P, Tsakountakis N, Verheij TJ, Goossens H, Butler CC, Beutels P, . (2022). E trial in 15 European countries. The European journal of health economics : HEPAC : health economics in prevention and care
Kuylen EJ, Torneri A, Willem L, Libin PJK, Abrams S, Coletti P, Franco N, Verelst F, Beutels P, Liesenborgs J, Hens N. (2022). Different forms of superspreading lead to different outcomes: Heterogeneity in infectiousness and contact behavior relevant for the case of SARS-CoV-2. PLoS computational biology, 18(8)
Tsuzuki S, Miyazato Y, Terada M, Morioka S, Ohmagari N, Beutels P. (2022). Impact of long-COVID on health-related quality of life in Japanese COVID-19 patients. Health and quality of life outcomes, 20(1)
Hoang TV, Willem L, Coletti P, Van Kerckhove K, Minnen J, Beutels P, Hens N. (2022). Exploring human mixing patterns based on time use and social contact data and their implications for infectious disease transmission models. BMC infectious diseases, 22(1)
Li X, Bilcke J, Vázquez Fernández L, Bont L, Willem L, Wisløff T, Jit M, Beutels P, . (2022). Cost-effectiveness of Respiratory Syncytial Virus Disease Prevention Strategies: Maternal Vaccine Versus Seasonal or Year-Round Monoclonal Antibody Program in Norwegian Children. The Journal of infectious diseases
Ekinci E, Van Heirstraeten L, Willen L, Desmet S, Wouters I, Vermeulen H, Lammens C, Goossens H, Van Damme P, Verhaegen J, Beutels P, Theeten H, Malhotra-Kumar S, . (2022). Serotype 19A and 6C account for one third of pneumococcal carriage among Belgian day-care children four years after a shift to a lower-valent PCV. Journal of the Pediatric Infectious Diseases Society
Mao Z, Li X, Korsten K, Bont L, Butler C, Wildenbeest J, Coenen S, Hens N, Bilcke J, Beutels P, . (2022). Economic Burden and Health-Related Quality of Life of Respiratory Syncytial Virus and Influenza Infection in European Community-Dwelling Older Adults. The Journal of infectious diseases, 226(Suppl 1)
Vranckx M, Faes C, Molenberghs G, Hens N, Beutels P, Van Damme P, Aerts J, Petrof O, Pepermans K, Neyens T. (2022). A spatial model to jointly analyze self-reported survey data of COVID-19 symptoms and official COVID-19 incidence data. Biometrical journal. Biometrische Zeitschrift
Mazur NI, Terstappen J, Baral R, Bardají A, Beutels P, Buchholz UJ, Cohen C, Crowe JE Jr., Cutland CL, Eckert L, Feikin D, Fitzpatrick T, Fong Y, Graham BS, Heikkinen T, Higgins D, Hirve S, Klugman KP, Kragten-Tabatabaie L, Lemey P, Libster R, Löwensteyn Y, Mejias A, Munoz FM, Munywoki PK, Mwananyanda L, Nair H, Nunes MC, Ramilo O, Richmond P, Ruckwardt TJ, Sande C, Srikantiah P, Thacker N, Waldstein KA, Weinberger D, Wildenbeest J, Wiseman D, Zar HJ, Zambon M, Bont L. (2022). Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape. The Lancet. Infectious diseases
Wong KLM, Gimma A, Paixao ES, , Faes C, Beutels P, Hens N, Jarvis CI, Edmunds WJ. (2022). Pregnancy during COVID-19: social contact patterns and vaccine coverage of pregnant women from CoMix in 19 European countries. BMC pregnancy and childbirth, 22(1)
Tsuzuki S, Asai Y, Ibuka Y, Nakaya T, Ohmagari N, Hens N, Beutels P. (2022). Social contact patterns in Japan in the COVID-19 pandemic during and after the Tokyo Olympic Games. Journal of global health, (12)
Jit M, Ananthakrishnan A, McKee M, Wouters OJ, Beutels P, Teerawattananon Y. (2021). Multi-country collaboration in responding to global infectious disease threats: lessons for Europe from the COVID-19 pandemic. The Lancet regional health. Europe, (9)
Valckx S, Crèvecoeur J, Verelst F, Vranckx M, Hendrickx G, Hens N, Van Damme P, Pepermans K, Beutels P, Neyens T. (2021). Individual factors influencing COVID-19 vaccine acceptance in between and during pandemic waves (July-December 2020). Vaccine
Iftekhar EN, Priesemann V, Balling R, Bauer S, Beutels P, Calero Valdez A, Cuschieri S, Czypionka T, Dumpis U, Glaab E, Grill E, Hanson C, Hotulainen P, Klimek P, Kretzschmar M, Krüger T, Krutzinna J, Low N, Machado H, Martins C, McKee M, Mohr SB, Nassehi A, Perc M, Petelos E, Pickersgill M, Prainsack B, Rocklöv J, Schernhammer E, Staines A, Szczurek E, Tsiodras S, Van Gucht S, Willeit P. (2021). A look into the future of the COVID-19 pandemic in Europe: an expert consultation. The Lancet regional health. Europe
Coletti P, Libin P, Petrof O, Willem L, Abrams S, Herzog SA, Faes C, Kuylen E, Wambua J, Beutels P, Hens N. (2021). A data-driven metapopulation model for the Belgian COVID-19 epidemic: assessing the impact of lockdown and exit strategies. BMC infectious diseases, 21(1)
Verelst F, Hermans L, Vercruysse S, Gimma A, Coletti P, Backer JA, Wong KLM, Wambua J, van Zandvoort K, Willem L, Bogaardt L, Faes C, Jarvis CI, Wallinga J, Edmunds WJ, Beutels P, Hens N. (2021). SOCRATES-CoMix: a platform for timely and open-source contact mixing data during and in between COVID-19 surges and interventions in over 20 European countries. BMC medicine, 19(1)
Beutels P, Verelst F. (2021). Ceci n'est pas un lit. Base capacity healthcare matters in a pandemic. The Lancet regional health. Europe, (2)
Li X, Bilcke J, van der Velden AW, Bongard E, Bruyndonckx R, Sundvall PD, Harbin NJ, Coenen S, Francis N, Bruno P, Garcia-Sangenis A, Glinz D, Kosiek K, Mikó-Pauer R, Radzeviciene Jurgute R, Seifert B, Tsakountakis N, Aabenhus R, Butler CC, Beutels P. (2021). Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries: A Descriptive Analysis Alongside the Randomised Controlled ALIC(4)E Trial. Clinical drug investigation, 41(8)
Abrams S, Wambua J, Santermans E, Willem L, Kuylen E, Coletti P, Libin P, Faes C, Petrof O, Herzog SA, Beutels P, Hens N. (2021). Modelling the early phase of the Belgian COVID-19 epidemic using a stochastic compartmental model and studying its implied future trajectories. Epidemics, (35)
Verelst F, Beutels P, Hens N, Willem L. (2021). Workplace influenza vaccination to reduce employee absenteeism: An economic analysis from the employers' perspective. Vaccine
Hoang TV, Coletti P, Kifle YW, Kerckhove KV, Vercruysse S, Willem L, Beutels P, Hens N. (2021). Close contact infection dynamics over time: insights from a second large-scale social contact survey in Flanders, Belgium, in 2010-2011. BMC infectious diseases, 21(1)
Van Wilder L, Charafeddine R, Beutels P, Bruyndonckx R, Cleemput I, Demarest S, De Smedt D, Hens N, Scohy A, Speybroeck N, Van der Heyden J, Yokota RTC, Van Oyen H, Bilcke J, Devleesschauwer B. (2021). Belgian population norms for the EQ-5D-5L, 2018. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Verelst F, Kessels R, Willem L, Beutels P. (2021). No Such Thing as a Free-Rider? Understanding Drivers of Childhood and Adult Vaccination through a Multicountry Discrete Choice Experiment. Vaccines, 9(3)
Bilcke J, Beutels P. (2021). Generating, Presenting, and Interpreting Cost-Effectiveness Results in the Context of Uncertainty: A Tutorial for Deeper Knowledge and Better Practice. Medical decision making : an international journal of the Society for Medical Decision Making
Stuurman AL, Ciampini S, Vannacci A, Bella A, Rizzo C, Muñoz-Quiles C, Pandolfi E, Liyanage H, Haag M, Redlberger-Fritz M, Bonaiuti R, Beutels P. (2021). Factors driving choices between types and brands of influenza vaccines in general practice in Austria, Italy, Spain and the UK. PloS one, 16(6)
Tsuzuki S, Ohmagari N, Beutels P. (2021). The burden of isolation to the individual: a comparison between isolation for COVID-19 and for other influenza-like illnesses in Japan. Epidemiology and infection, (150)
Priesemann V, Balling R, Bauer S, Beutels P, Valdez AC, Cuschieri S, Czypionka T, Dumpis U, Glaab E, Grill E, Hotulainen P, Iftekhar EN, Krutzinna J, Lionis C, Machado H, Martins C, McKee M, Pavlakis GN, Perc M, Petelos E, Pickersgill M, Prainsack B, Rocklöv J, Schernhammer E, Szczurek E, Tsiodras S, Van Gucht S, Willeit P. (2021). Towards a European strategy to address the COVID-19 pandemic. Lancet
Willem L, Abrams S, Libin PJK, Coletti P, Kuylen E, Petrof O, Møgelmose S, Wambua J, Herzog SA, Faes C, Beutels P, Hens N. (2021). The impact of contact tracing and household bubbles on deconfinement strategies for COVID-19. Nature communications, 12(1)
Kayiba NK, Yobi DM, Devleesschauwer B, Mvumbi DM, Kabututu PZ, Likwela JL, Kalindula LA, DeMol P, Hayette MP, Mvumbi GL, Lusamba PD, Beutels P, Rosas-Aguirre A, Speybroeck N. (2021). Care-seeking behaviour and socio-economic burden associated with uncomplicated malaria in the Democratic Republic of Congo. Malaria journal, 20(1)
Ekinci E, Desmet S, Van Heirstraeten L, Mertens C, Wouters I, Beutels P, Verhaegen J, Malhotra-Kumar S, Theeten H, . (2021). Streptococcus pneumoniae Serotypes Carried by Young Children and Their Association With Acute Otitis Media During the Period 2016-2019. Frontiers in pediatrics, (9)
Hoogink J, Verelst F, Kessels R, van Hoek AJ, Timen A, Willem L, Beutels P, Wallinga J, de Wit GA. (2020). Preferential differences in vaccination decision-making for oneself or one's child in The Netherlands: a discrete choice experiment. BMC public health, 20(1)
Verelst F, Kuylen E, Beutels P. (2020). Indications for healthcare surge capacity in European countries facing an exponential increase in coronavirus disease (COVID-19) cases, March 2020. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 25(13)
Schenk J, Abrams S, Theeten H, Van Damme P, Beutels P, Hens N. (2020). Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis. The Lancet. Infectious diseases
Wouters I, Desmet S, Van Heirstraeten L, Herzog SA, Beutels P, Verhaegen J, Goossens H, Van Damme P, Malhotra-Kumar S, Theeten H, . (2020). How nasopharyngeal pneumococcal carriage evolved during and after a PCV13-to-PCV10 vaccination programme switch in Belgium, 2016 to 2018. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 25(5)
Annemans L, Beutels P, Bloom DE, De Backer W, Ethgen O, Luyten J, Van Wilder P, Willem L, Simoens S. (2020). Economic Evaluation of Vaccines: Belgian Reflections on the Need for a Broader Perspective. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 24(1)
Neyens T, Faes C, Vranckx M, Pepermans K, Hens N, Van Damme P, Molenberghs G, Aerts J, Beutels P. (2020). Can COVID-19 symptoms as reported in a large-scale online survey be used to optimise spatial predictions of COVID-19 incidence risk in Belgium?. Spatial and spatio-temporal epidemiology, (35)
Luyten J, Ogunjimi B, Beutels P. (2020). Aggregate Wellbeing as Foundation to Discourage Childhood Chickenpox Vaccination. The American journal of bioethics : AJOB, 20(9)
Pieters Z, Strong M, Pitzer VE, Beutels P, Bilcke J. (2020). A Computationally Efficient Method for Probabilistic Parameter Threshold Analysis for Health Economic Evaluations. Medical decision making : an international journal of the Society for Medical Decision Making, 40(5)
Luyten J, Kessels R, Vandermeulen C, Beutels P. (2020). Value Frameworks for Vaccines: Which Dimensions Are Most Relevant?. Vaccines, 8(4)
Bruyndonckx R, Coenen S, Butler C, Verheij T, Little P, Hens N, Beutels P, Ieven M, Goossens H, . (2020). Respiratory syncytial virus and influenza virus infection in adult primary care patients: Association of age with prevalence, diagnostic features and illness course. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, (95)
Baral R, Li X, Willem L, Antillon M, Vilajeliu A, Jit M, Beutels P, Pecenka C. (2020). The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models. Vaccine
Moreno-Gutierrez D, Rosas-Aguirre A, Llanos-Cuentas A, Bilcke J, Barboza JL, Hayette MP, Contreras-Mancilla J, Aguirre K, Gamboa D, Rodriguez H, Speybroeck N, Beutels P. (2020). Economic costs analysis of uncomplicated malaria case management in the Peruvian Amazon. Malaria journal, 19(1)
Varbanova V, Beutels P. (2020). Recent quantitative research on determinants of health in high income countries: A scoping review. PloS one, 15(9)
Willem L, Van Hoang T, Funk S, Coletti P, Beutels P, Hens N. (2020). SOCRATES: an online tool leveraging a social contact data sharing initiative to assess mitigation strategies for COVID-19. BMC research notes, 13(1)
Desmet S, Wouters I, Heirstraeten LV, Beutels P, Van Damme P, Malhotra-Kumar S, Maes P, Verhaegen J, Peetermans WE, Lagrou K, Theeten H. (2021). In-depth analysis of pneumococcal serotypes in Belgian children (2015-2018): Diversity, invasive disease potential, and antimicrobial susceptibility in carriage and disease. Vaccine, 39(2)
Bartholomeus E, De Neuter N, Suls A, Elias G, van der Heijden S, Keersmaekers N, Jansens H, Van Tendeloo V, Beutels P, Laukens K, Ogunjimi B, Mortier G, Meysman P, Van Damme P. (2020). Transcriptomic profiling of different responder types in adults after a Priorix® vaccination. Vaccine, 38(16)
Coletti P, Wambua J, Gimma A, Willem L, Vercruysse S, Vanhoutte B, Jarvis CI, Van Zandvoort K, Edmunds J, Beutels P, Hens N. (2020). CoMix: comparing mixing patterns in the Belgian population during and after lockdown. Scientific reports, 10(1)
Kuylen E, Willem L, Broeckhove J, Beutels P, Hens N. (2020). Clustering of susceptible individuals within households can drive measles outbreaks: an individual-based model exploration. Scientific reports, 10(1)
Li X, Willem L, Antillon M, Bilcke J, Jit M, Beutels P. (2020). Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countries. BMC medicine, 18(1)
Molenberghs G, Buyse M, Abrams S, Hens N, Beutels P, Faes C, Verbeke G, Van Damme P, Goossens H, Neyens T, Herzog S, Theeten H, Pepermans K, Abad AA, Van Keilegom I, Speybroeck N, Legrand C, De Buyser S, Hulstaert F. (2020). Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic: Perspective from a European country. Contemporary clinical trials, (99)
Willem Lander, Hoang Thang Va, Funk Sebastian, Coletti Pietro, Beutels Philippe, Hens Niel. (2020). SOCRATES: An online tool leveraging a social contact data sharing initiative to assess mitigation strategies for COVID-19. Cold Spring Harbor Laboratory Press
Verelst F, Kessels R, Delva W, Beutels P, Willem L. (2019). Drivers of vaccine decision-making in South Africa: A discrete choice experiment. Vaccine, 37(15)
Hoang T, Coletti P, Melegaro A, Wallinga J, Grijalva CG, Edmunds JW, Beutels P, Hens N. (2019). A Systematic Review of Social Contact Surveys to Inform Transmission Models of Close-contact Infections. Epidemiology (Cambridge, Mass.), 30(5)
Bilcke J, Verelst F, Beutels P. (2018). Sponsorship Bias in Base-Case Values and Uncertainty Bounds of Health Economic Evaluations? A Systematic Review of Herpes Zoster Vaccination. Medical decision making : an international journal of the Society for Medical Decision Making, 38(6)
Goeyvaerts N, Santermans E, Potter G, Torneri A, Van Kerckhove K, Willem L, Aerts M, Beutels P, Hens N. (2018). Household members do not contact each other at random: implications for infectious disease modelling. Proceedings. Biological sciences, 285(1893)
De Neuter N, Bartholomeus E, Elias G, Keersmaekers N, Suls A, Jansens H, Smits E, Hens N, Beutels P, Van Damme P, Mortier G, Van Tendeloo V, Laukens K, Meysman P, Ogunjimi B. (2019). Memory CD4(+) T cell receptor repertoire data mining as a tool for identifying cytomegalovirus serostatus. Genes and immunity, 20(3)
Bartholomeus E, De Neuter N, Meysman P, Suls A, Keersmaekers N, Elias G, Jansens H, Hens N, Smits E, Van Tendeloo V, Beutels P, Van Damme P, Ogunjimi B, Laukens K, Mortier G. (2018). Transcriptome profiling in blood before and after hepatitis B vaccination shows significant differences in gene expression between responders and non-responders. Vaccine, 36(42)
Verelst F, Willem L, Kessels R, Beutels P. (2018). Individual decisions to vaccinate one's child or oneself: A discrete choice experiment rejecting free-riding motives. Social science & medicine (1982), (207)
Willem L, Blommaert A, Hanquet G, Thiry N, Bilcke J, Theeten H, Verhaegen J, Goossens H, Beutels P. (2018). Economic evaluation of pneumococcal vaccines for adults aged over 50 years in Belgium. Human vaccines & immunotherapeutics, 14(5)
Verelst F, Willem L, Kessels R, Beutels P. (2018). Corrigendum to 'Individual decisions to vaccinate one's child or oneself: A discrete choice experiment rejecting free-riding motives' Soc. Sci. Med. 207 (2018) 106-116. Social science & medicine (1982), (217)
Willem L, Verelst F, Bilcke J, Hens N, Beutels P. (2017). Lessons from a decade of individual-based models for infectious disease transmission: a systematic review (2006-2015). BMC infectious diseases, 17(1)
Blommaert A, Bilcke J, Willem L, Verhaegen J, Goossens H, Beutels P. (2016). The cost-effectiveness of pneumococcal vaccination in healthy adults over 50: An exploration of influential factors for Belgium. Vaccine, 34(18)
Kifle YW, Goeyvaerts N, Van Kerckhove K, Willem L, Kucharski A, Faes C, Leirs H, Hens N, Beutels P. (2016). Correction: Animal Ownership and Touching Enrich the Context of Social Contacts Relevant to the Spread of Human Infectious Diseases. PloS one, 11(2)
Verelst F, Willem L, Beutels P. (2016). Behavioural Change Models for Infectious Disease Transmission: A Systematic Review (2010-2015). Journal of the Royal Society, Interface, 13(125)
Goeyvaerts N, Willem L, Van Kerckhove K, Vandendijck Y, Hanquet G, Beutels P, Hens N. (2015). Estimating dynamic transmission model parameters for seasonal influenza by fitting to age and season-specific influenza-like illness incidence. Epidemics, (13)
Ultsch B, Damm O, Beutels P, Bilcke J, Brüggenjürgen B, Gerber-Grote A, Greiner W, Hanquet G, Hutubessy R, Jit M, Knol M, von Kries R, Kuhlmann A, Levy-Bruhl D, Perleth M, Postma M, Salo H, Siebert U, Wasem J, Wichmann O. (2016). Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community. PharmacoEconomics, 34(3)
Kifle YW, Goeyvaerts N, Van Kerckhove K, Willem L, Kucharski A, Faes C, Leirs H, Hens N, Beutels P. (2015). Animal Ownership and Touching Enrich the Context of Social Contacts Relevant to the Spread of Human Infectious Diseases. PloS one, 10(7)
Ogunjimi B, Willem L, Beutels P, Hens N. (2015). Integrating between-host transmission and within-host immunity to analyze the impact of varicella vaccination on zoster. eLife, (4)
Willem L, Stijven S, Tijskens E, Beutels P, Hens N, Broeckhove J. (2015). Optimizing agent-based transmission models for infectious diseases. BMC bioinformatics, (16)
Willem L, Stijven S, Vladislavleva E, Broeckhove J, Beutels P, Hens N. (2014). Active learning to understand infectious disease models and improve policy making. PLoS computational biology, 10(4)
Ogunjimi B, Buntinx F, Bartholomeeusen S, Terpstra I, De Haes I, Willem L, Elli S, Bilcke J, Van Damme P, Coenen S, Beutels P. (2015). Herpes zoster is associated with herpes simplex and other infections in under 60 year-olds. The Journal of infection, 70(2)
Newall AT, Jit M, Beutels P. (2012). Economic evaluations of childhood influenza vaccination: a critical review. PharmacoEconomics, 30(8)
Willem L, Van Kerckhove K, Chao DL, Hens N, Beutels P. (2012). A nice day for an infection? Weather conditions and social contact patterns relevant to influenza transmission. PloS one, 7(11)
Bilcke J, Marais C, Ogunjimi B, Willem L, Hens N, Beutels P. (2012). Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in Belgium. Vaccine, 30(3)
Hens N, Van Ranst M, Aerts M, Robesyn E, Van Damme P, Beutels P. (2011). Estimating the effective reproduction number for pandemic influenza from notification data made publicly available in real time: a multi-country analysis for influenza A/H1N1v 2009. Vaccine, 29(5)
Jit M, Bilcke J, Mangen MJ, Salo H, Melliez H, Edmunds WJ, Yazdan Y, Beutels P. (2009). The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe. Vaccine, 27(44)
Hens N, Ayele GM, Goeyvaerts N, Aerts M, Mossong J, Edmunds JW, Beutels P. (2009). Estimating the impact of school closure on social mixing behaviour and the transmission of close contact infections in eight European countries. BMC infectious diseases, (9)
Hens N, Goeyvaerts N, Aerts M, Shkedy Z, Van Damme P, Beutels P. (2009). Mining social mixing patterns for infectious disease models based on a two-day population survey in Belgium. BMC infectious diseases, (9)
If you’d like to update your profile, please email modifications to questions@midasnetwork.us.